Wichita, KS 的 高血壓 臨床試驗
8 項針對 高血壓 的研究正在 Wichita（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
招募中
- Cardiovascular Research Institute of Kansas, Wichita
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- Tekton Research - Wichita, Wichita
- AMR El Dorado, El Dorado · 距離 27 英里
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
招募中3 期
- Research Site, Wichita
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
招募中3 期
- Clinical Trial Site, Wichita
- Clinical Trial Site, Wichita
Global Paradise System US Post Approval Study
招募中觀察性研究
- Ascension via Christi St. Francis, Wichita
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
招募中2 期
- Alliance for Multispecialty Research, Wichita
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
招募中2 期
- Alliance for Multispecialty Research, Wichita
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
招募中2 期
- Vanda Investigative Site, Wichita
- Vanda Investigative Site, El Dorado · 距離 27 英里
其他城市的 高血壓 試驗
- Chicago, IL21 項研究
- Boston, MA21 項研究
- Dallas, TX16 項研究
- Nashville, TN13 項研究
- Houston, TX11 項研究
- Birmingham, AL11 項研究
- Durham, NC10 項研究
- Atlanta, GA10 項研究
- Tucson, AZ10 項研究
- New York City, NY9 項研究
- Miami, FL9 項研究
- Baltimore, MD9 項研究
Wichita 的其他研究
- 肥胖症11 項研究
- 第二型糖尿病10 項研究
- 過重8 項研究
- 心臟衰竭8 項研究
- 冠狀動脈疾病7 項研究
- 乳癌5 項研究
- 主動脈瓣狹窄5 項研究
- 非小細胞肺癌5 項研究
- 肺癌5 項研究
- 大腸直腸癌4 項研究
- 心血管疾病4 項研究
- 糖尿病3 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。